Crohn's disease trials in New Zealand

2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  Where

  Auckland, Dunedin, Lower Hutt

  Age

  16 years to 80 years

  People

  1,200 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06430801 · EU 2023-508636-61-00
• Phase 3Taking people
  A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  Where

  Lower Hutt

  Age

  16 years to 80 years

  People

  751 worldwide

  Run by

  Sanofi

  See details and how to joinNCT07184944